INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 19S · 3 late74 trades$23.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04CFCheng Chi Fung0B / 42S42 trades$15.33M
  5. 05RARothblatt Martine A0B / 33S33 trades$5.50M
  6. 06RJRubinstein Julie0B / 32S32 trades$5.55M
  7. 07LBLeach Bryan0B / 30S30 trades$7.97M
  8. 08AOAtay Oguzhan0B / 30S30 trades$7.55M
  9. 09JDJenkins William D Jr0B / 30S30 trades$13.38M
  10. 10BSBiswas Sanjit0B / 28S28 trades$22.33M

Form 4 transactions

65,929 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
SM
Singh Inder MDirector
WLYWLYBJOHN WILEY & SONS, INC.
Grant or award
A$6,593
122 sh
Oct 22, 2026Oct 23, 2026
Page 130 of 1649
← PrevNext →
traded Oct 22, 2026
+1d
SEC Form 4

Evidence

9
SL
Stillwell Mary-LeeSVP and Controller
VZVERIZON COMMUNICATIONS INC
Grant or award
A$585
45 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC Form 4

Evidence

8
PE
Pershing EdwardDirector, CEO, 10% Owner
PVCTPROVECTUS BIOPHARMACEUTICALS, INC.
Option exercise
M—Oct 23, 2026Oct 23, 2026
traded Oct 23, 2026
+0dSEC Form 4

Evidence

8
BA
Borgeson John A.Chief Financial Officer
KODKodiak Sciences Inc.
Open-market sale · 10b5-1 plan
SELL$187K
2,000 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

8
BA
Borgeson John A.Chief Financial Officer
KODKodiak Sciences Inc.
Open-market sale · 10b5-1 plan
SELL$185K
2,000 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

8
GS
Gheuens SarahChief Medical Officer
AGIOAGIOS PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$56K
1,489 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

8
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$29K
120 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC Form 4

Evidence

8
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$46K
194 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

8
BA
Borgeson John A.Chief Financial Officer
KODKodiak Sciences Inc.
Open-market sale · 10b5-1 plan
SELL$150K
1,677 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

8
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$18K
80 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

6
BA
Borgeson John A.Chief Financial Officer
KODKodiak Sciences Inc.
Option exercise · 10b5-1 plan
M$75K
30.0K sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

6
HJ
Honeycutt JenniferDirector, President and CEO
VLTOVeralto Corp
Option exercise · 10b5-1 plan
M$204K
7,098 sh
Oct 23, 2026Oct 23, 2026
traded Oct 23, 2026
+0dSEC Form 4

Evidence

5
RR
rahim ramiEVP, Pres GM Networking
HPEHewlett Packard Enterprise Co
Grant or award · 10b5-1 plan
A—
579 sh
Oct 16, 2026Oct 23, 2026
traded Oct 16, 2026
+7dSEC Form 4

Evidence

5
RR
rahim ramiEVP, Pres GM Networking
HPEHewlett Packard Enterprise Co
Grant or award · 10b5-1 plan
A—
252 sh
Oct 16, 2026Oct 23, 2026
traded Oct 16, 2026
+7dSEC Form 4

Evidence

5
BA
Borgeson John A.Chief Financial Officer
KODKodiak Sciences Inc.
Open-market sale · 10b5-1 plan
SELL$9,491
100 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

5
LD
Lentz DanielCFO & COO
CMRCCommerce.com, Inc.
Tax withholding
F$6,241
1,724 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

4
LB
Leach BryanDirector, CEO AND PRESIDENT, 10% Owner
IBTAIbotta, Inc.
Option exercise · 10b5-1 plan
M—
15.3K sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

4
GK
Goel Rajeev K.Director, CHIEF EXECUTIVE OFFICER, 10% Owner
PUBMPubMatic, Inc.
Derivative conversion · 10b5-1 plan
C—
34.4K sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC Form 4

Evidence

4
RM
Rogers Daniel MarkDirector, Chief Executive Officer
ASANAsana, Inc.
Open-market sale · 10b5-1 plan
SELL$227K
19.7K sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC Form 4

Evidence

4
AA
Ashish AroraDirector, Chief Executive Officer, 10% Owner
CRCTCricut, Inc.
Open-market sale · 10b5-1 plan
SELL$379K
60.0K sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC Form 4

Evidence

4
AA
Ashish AroraDirector, Chief Executive Officer, 10% Owner
CRCTCricut, Inc.
Open-market sale · 10b5-1 plan
SELL$379K
60.0K sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

4
GK
Goel Rajeev K.Director, CHIEF EXECUTIVE OFFICER, 10% Owner
PUBMPubMatic, Inc.
Option exercise · 10b5-1 plan
M—
21.9K sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC Form 4

Evidence

4
SI
Sarowitz Steven IDirector, 10% Owner
PCTYPaylocity Holding Corp
Open-market sale · 10b5-1 plan
SELL$463K
2,728 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

4
SI
Sarowitz Steven IDirector, 10% Owner
PCTYPaylocity Holding Corp
Open-market sale · 10b5-1 plan
SELL$267K
1,564 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

4
AA
Ashish AroraDirector, Chief Executive Officer, 10% Owner
CRCTCricut, Inc.
Open-market sale · 10b5-1 plan
SELL$376K
60.0K sh
Oct 23, 2026Oct 23, 2026
traded Oct 23, 2026
+0dSEC Form 4

Evidence

3
BA
Borgeson John A.Chief Financial Officer
KODKodiak Sciences Inc.
Option exercise · 10b5-1 plan
M—
30.0K sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

3
GS
Gheuens SarahChief Medical Officer
AGIOAGIOS PHARMACEUTICALS, INC.
Option exercise · 10b5-1 plan
M—
1,489 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

2
MK
Malady KyleEVP and Group CEO-VZ Business
VZVERIZON COMMUNICATIONS INC
Grant or award
A$1,738
135 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC Form 4

Evidence

1
SI
Sarowitz Steven IDirector, 10% Owner
PCTYPaylocity Holding Corp
Open-market sale · 10b5-1 plan
SELL$154K
900 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

1
SI
Sarowitz Steven IDirector, 10% Owner
PCTYPaylocity Holding Corp
Open-market sale · 10b5-1 plan
SELL$93K
552 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

1
GS
Gheuens SarahChief Medical Officer
AGIOAGIOS PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$19K
500 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC Form 4

Evidence

0
FJ
Fox-Geen JeremyChief Financial Officer
CRCLCircle Internet Group, Inc.
Option exercise · 10b5-1 plan
M$152K
15.0K sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

0
LB
Leach BryanDirector, CEO AND PRESIDENT, 10% Owner
IBTAIbotta, Inc.
Derivative conversion · 10b5-1 plan
C—
6,573 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

0
GS
Gheuens SarahChief Medical Officer
AGIOAGIOS PHARMACEUTICALS, INC.
Option exercise · 10b5-1 plan
M$13K
500 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC Form 4

Evidence

0
GS
Gheuens SarahChief Medical Officer
AGIOAGIOS PHARMACEUTICALS, INC.
Option exercise · 10b5-1 plan
M$37K
1,489 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

0
GK
Goel Rajeev K.Director, CHIEF EXECUTIVE OFFICER, 10% Owner
PUBMPubMatic, Inc.
Option exercise · 10b5-1 plan
M$47K
21.9K sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC Form 4

Evidence

0
Bhatt BaijuDirector
HOODRobinhood Markets, Inc.
Derivative conversion · 10b5-1 plan
C—
50.9K sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

0
LB
Leach BryanDirector, CEO AND PRESIDENT, 10% Owner
IBTAIbotta, Inc.
Derivative conversion · 10b5-1 plan
C—
6,573 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

0
LB
Leach BryanDirector, CEO AND PRESIDENT, 10% Owner
IBTAIbotta, Inc.
Option exercise · 10b5-1 plan
M—
21.4K sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

0
Robinhood Markets, Inc.10% Owner
RVIRobinhood Ventures Fund I
Open-market sale · 10b5-1 plan
SELL$2,126
85 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  3. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  4. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  5. SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  6. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  7. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
  8. SELLBCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K